FFA
CSTL icon

Farther Finance Advisors’s Castle Biosciences CSTL Stock Holding History

Farther Finance Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Sell
1,806
-582
-24% -$13K ﹤0.01% 3366
2026
Q1 		$59.8K Sell
2,388
-949
-28% -$31.1K ﹤0.01% 2866
2025
Q4 		$130K Buy
3,337
+1,945
+140% +$62.7K ﹤0.01% 2182
2025
Q3 		$31.7K Buy
1,392
+1,391
+139,100% +$28.3K ﹤0.01% 2731
2025
Q2 		$20 Sell
1
-4
-80% -$74 ﹤0.01% 4429
2025
Q1 		$99 Hold
5
– – ﹤0.01% 4064
2024
Q4 		$133 Hold
5
– – ﹤0.01% 3739
2024
Q3 		$143 Sell
5
-91
-95% -$2.32K ﹤0.01% 3724
2024
Q2 		$2.03K Buy
96
+91
+1,820% +$2.03K ﹤0.01% 2786
2024
Q1 		$111 Hold
5
– – ﹤0.01% 3365
2023
Q4 		$108 Buy
+5
New +$88 ﹤0.01% 3294

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's CSTL Position: Q2 2026 in Review

Farther Finance Advisors reduced its Castle Biosciences (CSTL) stake by 24% in Q2 2026, selling an estimated $13K and leaving 1,806 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Farther Finance Advisors first reported a position in CSTL in Q4 2023 and has held it in 11 quarters since. The position peaked at $130K in Q4 2025. 9 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Farther Finance Advisors held 1,806 shares of Castle Biosciences worth $43.1K as of Q2 2026.
  • Farther Finance Advisors sold 582 Castle Biosciences shares in Q2 2026, an estimated $13K.
  • Castle Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3366 holding.
  • Farther Finance Advisors first reported a position in Castle Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Castle Biosciences position peaked at $130K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.